30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Badrul Chowdhury

Track

Insider profile

Currently holds positions in Savara Inc and Proteostasis Therapeutics Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 25% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer Savara Inc Nov. 18, 2019 -
Director Proteostasis Therapeutics Inc May 12, 2019 -
Badrul Chowdhury's trades of Savara Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-09 2021-12-09
US Savara Inc (SVRA)
B Purchase
24,272 +41.8%
10.10
US$3,761,143 		24,272 +41.8% 10.10 US$3,761,143
2021-05-17 2021-05-17
US Savara Inc (SVRA)
PlS Planned sale
33,447 -37.2%
305.02
US$3,038,125 		33,447 -37.2% 305.02 US$3,038,125